HIGHLIGHTS
- who: Eleonora Allocati and colleagues from the Center for Health Regulatory, Mario Negri Institute for Pharmacological Research IRCCS, Milan, Italy, Department of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow have published the Article: Switching Among Biosimilars: A Review of Clinical Evidence, in the Journal: (JOURNAL)
- future: Hurdles in the development of biosimilars including the request for studies demonstrating their efficacy and safety after switching can appear disproportionate and may discourage companies from developing biosimilars which will be detrimental to key stakeholder groups in the future.
SUMMARY
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.